Last reviewed · How we verify

NCT06140342

A Music-Based Mobile App for People Living With Alzheimer's Disease and Related Dementias (ADRD)

Status unknown Last updated 24 November 2023
What this trial tests

trial testing Feasibility study of music-based mobile app in Dementia in 20 participants. Status unknown.

Timeline
1 August 2023
Primary endpoint
1 January 2025
1 January 2025

Quick facts

Lead sponsorAutotune Me LLC
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment20
Start date1 August 2023
Primary completion1 January 2025
Estimated completion1 January 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Autotune Me LLC

Who can join

Eligibility, any sex, with Dementia or Agitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this pilot is to develop a mobile application that detects physiological measures of individuals with Alzheimer's disease and related dementias and triggers auto-play of personalized songs in a wearable device. The investigators will test the feasibility and acceptability of the app. This app may be an important tool to include in daily caregiving in a home setting by extending established benefits of music therapy for people with Alzheimer's disease and related dementias.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dementia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06140342.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing